Home » Stocks » Innovation Pharmaceuticals

Innovation Pharmaceuticals Inc. (IPIX)

Stock Price: $0.270 USD 0.045 (19.95%)
Updated Aug 3, 2020 5:19 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 89.14M
Revenue (ttm) 400,000
Net Income (ttm) -6.69M
Shares Out 292.75M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $0.270
Previous Close $0.225
Change ($) 0.045
Change (%) 19.95%
Day's Open 0.218
Day's Range 0.215 - 0.297
Day's Volume 1,035,908
52-Week Range 0.050 - 0.650

More Stats

Market Cap 89.14M
Enterprise Value 90.77M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 292.75M
Float 248.45M
EPS (basic) -0.03
EPS (diluted) -0.03
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.60
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 222.84
PB Ratio n/a
Revenue 400,000
Operating Income -4.54M
Net Income -6.69M
Free Cash Flow -3.67M
Net Cash -1.63M
Net Cash / Share 0.00
Gross Margin n/a
Operating Margin -1,135.25%
Profit Margin -1,671.20%
FCF Margin -918.50%
ROA -70.82%
ROE n/a
ROIC 126.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-6.45-13.94-15.34-12.65-12.96-8.04-2.98-4.20-5.72-3.36
Net Income-8.68-16.36-15.54-12.85-13.15-8.25-3.22-4.89-5.94-3.43
Shares Outstanding17814512712011510594.9890.1690.3091.86
Earnings Per Share-0.05-0.11-0.12-0.11-0.11-0.10-0.04-0.06-0.06-0.04
Operating Cash Flow-6.33-13.28-11.71-9.89-13.07-7.51-1.91-0.69-0.74-1.11
Capital Expenditures0.040.01-0.06-0.07-0.01-0.02----
Free Cash Flow-6.29-13.27-11.77-9.96-13.08-7.53-1.91-0.69-0.74-1.11
Cash & Equivalents0.582.424.146.318.414.992.960.030.070.00
Total Debt1.922.
Net Cash / Debt-1.340.402.124.296.392.970.93-1.99-2.45-1.46
Book Value-4.13-2.15-1.462.967.021.21-5.17-7.63-7.29-4.80
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Innovation Pharmaceuticals Inc.
Country United States
Employees 4
CEO Leo Ehrlich

Stock Information

Ticker Symbol IPIX
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: IPIX


Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its's lead drug compound is Brilacidin, which is in Phase III study for the treatment of oral mucositis, inflammatory bowel disease, and acute bacterial skin and skin structure infection. The company also develops Kevetrin, a lead anti-cancer compound for treating ovarian cancer. In addition, it owns other compounds for treating diseases, including autism, arthritis, asthma, MS/ALS/Parkinson's, cancer, hypertensive emergency, and bacterial and fungal infections. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Beverly, Massachusetts.